Cargando…
Integrated lipidomics and network pharmacology analysis to reveal the mechanisms of berberine in the treatment of hyperlipidemia
BACKGROUND: Berberine (BBR), an isoquinoline alkaloid isolated from Rhizoma Coptis, is widely used in the treatment of hyperlipidemia (HLP) in China. At present, the efficacy of BBR against HLP is relatively clear, but there are few researches on its mechanism. The purpose of this study was to evalu...
Autores principales: | Chen, Yuting, Li, Kaipeng, Zhao, Han, Hao, Zhangsen, Yang, Yuxin, Gao, Mingming, Zhao, Ding |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461205/ https://www.ncbi.nlm.nih.gov/pubmed/36076294 http://dx.doi.org/10.1186/s12967-022-03623-0 |
Ejemplares similares
-
Network Pharmacology and Bioinformatics Methods Reveal the Mechanism of Berberine in the Treatment of Ischaemic Stroke
por: Song, Ke, et al.
Publicado: (2022) -
Gut Microbiota-Mediated Personalized Treatment of Hyperlipidemia Using Berberine
por: Wang, Yan, et al.
Publicado: (2017) -
Mechanisms of Berberine for the Treatment of Atherosclerosis Based on Network Pharmacology
por: Xie, Xuejiao, et al.
Publicado: (2020) -
Untargeted lipidomics and metagenomics reveal the mechanism of aspirin eugenol ester relieving hyperlipidemia in ApoE−/− mice
por: Lu, Xiao-Rong, et al.
Publicado: (2022) -
The Potential Mechanism of Wuwei Qingzhuo San against Hyperlipidemia Based on TCM Network Pharmacology and Validation Experiments in Hyperlipidemia Hamster
por: Li, Jianliang, et al.
Publicado: (2020)